Globus Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Globus Medical generated cash of $243,499,000, which is more than the previous year. Cash used in financing activities reached the amount of -$231,821,000 last year. Net change in cash is therefore $316,826,000.
Cash Flow
| 2014 | 79.17M | -100M | 12.94M |
|---|---|---|---|
| 2015 | 121.95M | -150.55M | 6.32M |
| 2016 | 171.89M | -99.55M | 2.04M |
| 2017 | 159.53M | -111.27M | 1.62M |
| 2018 | 181.64M | -193.02M | 32.57M |
| 2019 | 171.97M | -140.28M | 24.43M |
| 2020 | 198.79M | -117.32M | -38.66M |
| 2021 | 276.27M | -375.93M | 54.14M |
| 2022 | 178.46M | -110.36M | -109.96M |
| 2023 | 243.49M | 302.96M | -231.82M |
GMED Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 150.46M | 193.06M | 239.39M | 195.72M | 139.74M | 118.81M | 66.95M | 60.15M | 82.26M | 89.96M |
Operating activities | ||||||||||
Net income | 122.87M | 190.16M | 149.19M | 102.28M | 155.21M | 156.47M | 107.34M | 104.34M | 112.78M | 92.48M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 144.73M | 68.25M | 69.86M | 62.87M | 52.73M | 41.63M | 42.06M | 38.77M | 24.08M | 21.75M |
Stock-based compensation expense | 52.74M | 32.81M | 30.58M | 27.07M | 26.08M | 0 | 14.68M | 11.38M | 9.63M | 7.11M |
| Deferred income tax benefit | 52.74M | 32.81M | 30.58M | 27.07M | 26.08M | 0 | 14.68M | 11.38M | 9.63M | 7.11M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -49.91M | -50.84M | -25.89M | 10.69M | -18.30M | -21.78M | -24.95M | -4.66M | -4.19M | -12.66M |
Inventories | -70.32M | -61.74M | -11.97M | -50.11M | -50.01M | -31.38M | -5.27M | -10.50M | -19.32M | -18.00M |
Accounts payable | -14.22M | 14.41M | 3.68M | -6.35M | 773K | -3.00M | 9.84M | -23K | -9.18M | 7.33M |
Cash generated by operating activities | 243.49M | 178.46M | 276.27M | 198.79M | 171.97M | 181.64M | 159.53M | 171.89M | 121.95M | 79.17M |
Investing activities | ||||||||||
Purchases Of Investments | -100.64M | -419.53M | -622.35M | -223.54M | -346.52M | -537.94M | -392.89M | -287.26M | -297.70M | -251.42M |
Investments In Property Plant And Equipment | -78.27M | -74.04M | -56.89M | -63.65M | -70.75M | -59.69M | -51.30M | -40.90M | -50.76M | -24.75M |
Acquisitions Net | -296.02M | -31.43M | -34.48M | -33.48M | -23.79M | -14.82M | -29.94M | -76.06M | -48.51M | -36.12M |
Cash generated by investing activities | 302.96M | -110.36M | -375.93M | -117.32M | -140.28M | -193.02M | -111.27M | -99.55M | -150.55M | -100M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 63.49M | 72.32M | 31.03M | 39.30M | 11.73M | 5.87M | 5.47M | 9.73M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -225.56M | -144.49M | 0 | -104.66M | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -231.82M | -109.96M | 54.14M | -38.66M | 24.43M | 32.57M | 1.62M | 2.04M | 6.32M | 12.94M |
Net Change In Cash | 316.82M | -42.60M | -46.32M | 43.67M | 55.97M | 20.93M | 51.86M | 72.48M | -22.11M | -7.69M |
Cash at end of period | 467.29M | 150.46M | 193.06M | 239.39M | 195.72M | 139.74M | 118.81M | 132.63M | 60.15M | 82.26M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |